Project Details
| Status | Active |
|---|---|
| Effective start/end date | 20/04/26 → 19/04/31 |
Clinical Trial Phase
- Phase I
- Phase II
- External Sponsor
A prospective randomized phase I/II trial of venetoclax treatment (26 cycles) with 6 cycles or 12 cycles of epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma AETHER trial (ABT199 + Epcoritamab THErapy for Relapsed/refractory CLL/SLL)
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research